We are live on ! Find out more
CMND icon

Clearmind Medicine
CMND

9 hedge funds and large institutions have $5.49M invested in Clearmind Medicine in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

13% more funds holding

Funds holding: 8 → 9 (+1)

0.01% less ownership

Funds ownership: 0.04% → 0.03% (-0.01%)

0% less capital invested

Capital invested by funds: $5.49M → $5.49M (-$3.11K)

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$54.9K
2
Citadel Advisors
Citadel Advisors
Florida
+$28.3K
3
GAM
Gotham Asset Management
New York
+$4.99K
4
Morgan Stanley
Morgan Stanley
New York
+$3.32K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.11K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$172K
2
HF
HRT Financial
New York
-$15K
3
AI
AdvisorShares Investments
Maryland
-$3.88K

CMND Hedge Fund Activity: Q4 2024 in Review

9 institutional investors reported a position in Clearmind Medicine (CMND) for Q4 2024, worth a combined $5.49M — down 0.06% from $5.49M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CMND positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $54.9K. The largest seller was UBS Group, exiting entirely with an estimated $172K sold.

  • 9 institutional investors held Clearmind Medicine (CMND) as of Q4 2024, up from 8 in Q3 2024.
  • Funds reported $5.49M of Clearmind Medicine stock for Q4 2024, down 0.06% quarter-over-quarter.
  • 3 funds opened new Clearmind Medicine positions in Q4 2024 and 2 closed out, a net change of +1 holder.
  • The largest Clearmind Medicine buyer in Q4 2024 was Virtu Financial, an estimated $54.9K added.
  • The largest Clearmind Medicine seller in Q4 2024 was UBS Group, an estimated $172K sold.

Based on aggregated 13F filings for Q4 2024.